[1]
Ivanova, D.; Zhelev, Z.; Getsov, P.; Nikolova, B.; Aoki, I.; Higashi, T.; Bakalova, R.; Vitamin, K. Redox-modulation, prevention of mitochondrial dysfunction and anticancer effect. Redox Biol., 2018, 16, 352-358.
[2]
Georgieva, E.; Ivanova, D.; Zhelev, Z.; Bakalova, R.; Gulubova, M.; Aoki, I. Mitochondrial dysfunction and redox imbalance as a diagnostic marker of “free radical diseases”. Anticancer Res., 2017, 37(10), 5373-5381.
[3]
Semkova, S.; Nikolova, B.; Tsoneva, I.; Antov, G.; Ivanova, D.; Angelov, A.; Zhelev, Z.; Bakalova, R. Redox-mediated anticancer activity of anti-parasitic drug fenbendazole in triple-negative breast cancer cells. Anticancer Res., 2023, 43(3), 1207-1212.
[4]
Bakalova, R.; Zhelev, Z.; Miller, T.; Aoki, I.; Higashi, T. New potential biomarker for stratification of patients for pharmacological vitamin C in adjuvant settings of cancer therapy. Redox Biol., 2020, 28, 101357.
[5]
Bakalova, R.; Aoki, I.; Zhelev, Z.; Higashi, T. Cellular redox imbalance on the crossroad between mitochondrial dysfunction, senescence, and proliferation. Redox Biol., 2022, 10, 2337.
